Your Tumors Best Treatment? A Space-Based Test Could Tell You
Summary
Encapsulate secured $3.63 million from NASA’s InSPA program and $1.25 million from the NSF SBIR program to advance its tumor-on-a-chip diagnostics. The company uses microgravity aboard the International Space Station to grow patient-derived tumors and test drug responses more accurately than on Earth. It also launched a larger clinical study with major cancer centers including UConn Health, Moffitt Cancer Center, and Memorial Sloan Kettering Cancer Center. The research aims to improve personalized cancer treatment and reveal tumor behaviors linked to metastasis.
Funding
Amount
$3.6M
Total raised
Date
July 31, 2025
Announcement date
Investors
ISS U.S. National Laboratory, Space Tango, Ralph Lauren Center for Cancer Care and Prevention, NASA - National Aeronautics and Space Administration
Lead investors
Company
encapsulate.bio
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected